SCHEMBL5217873

SCHEMBL5217873

O=C(O)CNC1CCC(c2ccccn2)CC1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DRD4 P21917 8/20 0.42
ALDH1A1 P00352 1/20 0.42
KMT2A Q03164 1/20 0.42
ITGB3 P05106 1/20 0.41
ITGA2B P08514 1/20 0.41
DRD2 P14416 4/20 0.41
DRD3 P35462 3/20 0.41
USP30 Q70CQ3 1/20 0.41
SMYD3 Q9H7B4 1/20 0.41
TRPV1 Q8NER1 2/20 0.41
HDAC3 O15379 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
HDAC9 Q9UKV0 1/20 0.40
HDAC5 Q9UQL6 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propionic Acid SCHEMBL29117403 0.80 DRD4 (0.46) DRD4ALDH1A1DRD2DRD3HDAC3
SCHEMBL5220249 0.79 ALDH1A1 (0.53) ALDH1A1
Acetic Acid SCHEMBL29178492 0.78 ALDH1A1 (0.46) DRD4ALDH1A1KMT2ADRD2DRD3
Carbamic Acid SCHEMBL10474895 0.78 ALDH1A1 (0.46) DRD4ALDH1A1KMT2ADRD2DRD3
SCHEMBL16606315 0.76 GRIN2B (0.43) DRD4ALDH1A1KMT2ADRD2DRD3
SCHEMBL659325 0.76 KDM4E (0.48) DRD4ALDH1A1KMT2ADRD2DRD3
SCHEMBL900225 0.76
SCHEMBL29448519 0.76
SCHEMBL22999404 0.75 NPC1 (0.51) DRD4DRD2DRD3HDAC3HDAC4
Formaldehyde SCHEMBL28000054 0.74 ALDH1A1 (0.47) DRD4ALDH1A1KMT2ADRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1399433-B1 FLUOROPYRROLIDINES AS DIPEPTIDYL PEPTIDASE INHIBITORS SMITHKLINE BEECHAM CORP (US) 2007-08-22 EP disclosed
US-7183290-B2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors SMITHKLINE BEECHAM CORPORATION (US) 2007-02-27 US disclosed
US-20040242636-A1 Enzyme inhibitors as antiinflammatory ageents for psoriasis, obesity SMITHKLINE BEECHAM CORPORATION 2004-12-02 US disclosed
EP-1399433-A2 FLUOROPYRROLIDINES AS DIPEPTIDYL PEPTIDASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2004-03-24 EP disclosed
WO-2003002553-A2 FLUOROPYRROLIDINES AS DIPEPTIDYL PEPTIDASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2003-01-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040242636-A1 Enzyme inhibitors as antiinflammatory ageents for psoriasis, obesity DPP4, DPP7, DPP3 DRD4 2303/4885ALDH1A1 531/4885KMT2A 2914/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.